Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome

被引:34
作者
Fulghesu, Anna Maria
Angioni, Stefano
Portoghese, Elaine
Milano, Francesca
Batetta, Barbara
Paoletti, Anna Maria
Melis, Gian Benedetto
机构
[1] Univ Cagliari, Sez Clin Ginecol Ostet & Fisiopatol Riproduz, Dipartimento Chirurg Maternoinfantile & Sci Immag, I-09124 Cagliari, Italy
[2] Univ Cagliari, Dipartimento Sci Biomed & Biotecnol, I-09124 Cagliari, Italy
关键词
hyperinsulinemia; HOMA; insulin resistance; OGTT; PCOS; ORAL GLUCOSE-TOLERANCE; INSULIN SENSITIVITY INDEXES; TERM NALTREXONE TREATMENT; OBESE WOMEN; LUTEINIZING-HORMONE; CLAMP TECHNIQUE; RESISTANCE; SECRETION; ADOLESCENTS; PREVALENCE;
D O I
10.1016/j.fertnstert.2006.01.024
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To verify whether the homeostatic model assessment (HOMA) test is a suitable method for the identification of metabolic deterioration in normal-weigh patients affected by polycystic ovary syndrome (PCOS). Design: Prospective clinical study. Setting: Academic clinic and research environment in Cagilari, Italy. Patient(s): Forty-nine PCOS normal-weight adolescent subjects, and 50 eumenorrheic, normal-weight, nonhirsute controls matched for age and body mass index (BMI). Intervention(s): History and physical examination, oral glucose tolerance (OGTT) and blood sampling, ultrasound. Main Outcome Measure(s): The HOMA score and integrated secretory area under the curve of insulin values (I-AUC) during the OGTT were calculated. Result(s): Normal insulin sensitivity was defined as upper control 95th percentile by HOMA values < 6.5, I-AUC at 180 minutes < 16,921, and I-AUC at 120 minutes < 11,817. When applying the calculated I-AUC cutoff, 27 PCOS patients were classified as normoinsulinemic and 22 as hyperinsulinemic, whereas using the calculated HOMA cuttoff, only 9 PCOS patients could be classified as insulin resistant (IR). Thirteen of the 40 non-IR presented with hyperinsulinemia; fasting glucose and insulin levels and HOMA scores were not sufficient to identify these subjects. Thus, the HOMA test displayed a low sensitivity (41%) and specificity (100%) in the diagnosis of the metabolic disorder disclosed by I-AUC. Moreover, analysis of I-AUC after 120 and 180 minutes revealed how the shorter evaluation period did not suffice for identification of all hyperinsulinemic subjects, implying an unrecognized condition in 11 of 22 subjects. Conclusion(s): In young, normal-weight patients with PCOS, the prevalence of hyperinsulinemia is not detectable by HOMA studies. The prevalence of IR was 18% according to HOMA evaluation, whereas hyperinsulinemia is not detectable by HOMA studies. The relevance of IR was 18% according to HOMA evaluation, whereas hyperinsulinemia was found in 44% of subjects examined by I-AUC. Normal-weight young PCOS patients should undergo a 3-hour OGTT to detect early metabolic abnormalities.
引用
收藏
页码:398 / 404
页数:7
相关论文
共 41 条
[1]
Hyperinsulinemia in African-American children - Decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity [J].
Arslanian, SA ;
Saad, H ;
Lewy, V ;
Danadian, K ;
Janosky, J .
DIABETES, 2002, 51 (10) :3014-3019
[2]
Glucose intolerance in obese adolescents with polycystic ovary syndrome:: Roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease [J].
Arslanian, SA ;
Lewy, VD ;
Danadian, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :66-71
[3]
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[5]
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity - Studies in subjects with various degrees of glucose tolerance and insulin sensitivity [J].
Bonora, E ;
Saggiani, F ;
Targher, G ;
Zenere, MB ;
Alberiche, M ;
Monauni, T ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2000, 23 (01) :57-63
[6]
BONORA E, 1984, J CLIN ENDOCR METAB, V59, P1121, DOI 10.1210/jcem-59-6-1121
[7]
Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome [J].
Carmina, E ;
Lobo, RA .
FERTILITY AND STERILITY, 2004, 82 (03) :661-665
[8]
Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome [J].
Ciampelli, M ;
Fulghesu, AM ;
Cucinelli, F ;
Pavone, V ;
Caruso, A ;
Mancuso, S ;
Lanzone, A .
HUMAN REPRODUCTION, 1997, 12 (09) :1897-1901
[9]
Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low-androgenic progestin [J].
Cibula, D ;
Fanta, M ;
Hill, M ;
Sindelka, G ;
Skrha, J ;
Zivny, J .
HUMAN REPRODUCTION, 2002, 17 (01) :76-82
[10]
Insulin sensitivity and coronary vasoreactivity:: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects [J].
Dagres, N ;
Saller, B ;
Haude, M ;
Hüsing, J ;
von Birgelen, C ;
Schmermund, A ;
Sack, S ;
Baumgart, D ;
Mann, K ;
Erbel, R .
CLINICAL ENDOCRINOLOGY, 2004, 61 (06) :724-731